BP

Bhumika Paliwal

Active Director Director DIN 09343536
DIN 09343536 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 5 active board seats
Past companies 15 historical roles
Total affiliations 20 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhumika Paliwal

Data last updated:

Bhumika Paliwal is a Director at Hertwich India Private Limited (since 2026), Director at Schwind India Eye-Tech Solutions Private Limited (since 2025) and Director at Rz Medtech Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Outsourcing and Engineering. Earlier, Bhumika Paliwal was a Director at Mic Chemicals Private Limited (2021–2024) and Director at Procos India Luxury Packaging Private Limited (2025) and 13 more.

DIN 09343536
Primary Designation Director
Industry Healthcare
First Appointment 01 Oct 2021
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hertwich India Private Limited U28230HR2026PTC148601
Director30 Jul 20262026Active
Director19 Dec 20252025Active
Rz Medtech Private Limited U32509HR2025PTC138204
Director12 Nov 20252025Active
Medicruiter India Private Limited U78100DL2025PTC457705
Director06 Nov 20252025Active
Neundoerfer India Private Limited U46590HR2025PTC137740
Director28 Oct 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mic Chemicals Private Limited U51430DL2021PTC387571
Director01 Oct 20212021Active
Director25 Mar 20252025Active
Director02 Apr 20252025Active
Seho Systems India Private Limited U46599GJ2024PTC154627
Director24 Aug 20242024Active
Director08 Aug 20242024Active
Director08 Sep 20232023Active
Director22 Jun 20242024₹1.6 Lakh (FY 2025)Active
Director26 May 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Schwind India Eye-Tech Solutions Private Limited
Medicruiter India Private Limited
Rz Medtech Private Limited
Neundoerfer India Private Limited
Premium access

Shareholding and investment profile for Bhumika Paliwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhumika Paliwal

Bhumika Paliwal currently holds 5 directorships: Hertwich India Private Limited (Director, since 30 Jul 2026); Schwind India Eye-Tech Solutions Private Limited (Director, since 19 Dec 2025); Rz Medtech Private Limited (Director, since 12 Nov 2025); Medicruiter India Private Limited (Director, since 06 Nov 2025); Neundoerfer India Private Limited (Director, since 28 Oct 2025).

Bhumika Paliwal was first appointed on 01 Oct 2021 as Director at Mic Chemicals Private Limited. The most recent appointment on record is 30 Jul 2026 at Hertwich India Private Limited.

Bhumika Paliwal held 15 earlier board appointments: Mic Chemicals Private Limited (Director, 01 Oct 2021 to 28 Mar 2024); Procos India Luxury Packaging Private Limited (Director, 25 Mar 2025 to 23 Jun 2025); Procos India International Luxury Packaging Private Limited (Director, 02 Apr 2025 to 23 Jun 2025); Seho Systems India Private Limited (Director, 24 Aug 2024 to 16 Jan 2025); Micgtm Customs Solutions India Private Limited (Director, 08 Aug 2024 to 26 Dec 2024); and 10 more.

The current boards of Bhumika Paliwal's companies include Rushak Anil Tadkalkar (Hertwich India Private Limited), Soumitra Suhas Dole (Hertwich India Private Limited), Shelly Bajaj (Schwind India Eye-Tech Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available